# Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients

> **NCT06956144** · — · RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 113 (estimated)

## Conditions studied

- Tumor
- Carbonic Anhydrase IX

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06956144
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-09
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 113 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06956144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06956144, "Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06956144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*